Long-term effect of radiocontrast-enhanced computed tomography on the renal function of chronic kidney disease patients

Clinical and Experimental Nephrology

Volumn 16, Issue 5, 2012, Pages 755-759

  Kim, Il Young ^a,b   Lee, Soo Bong ^a,b   Lee, Dong Won ^a,b   Song, Sang Heon ^c   Seong, Eun Young ^c   Kwak, Ihm Soo ^c  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University Yangsan Hospital   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

Author keywords

Chronic kidney disease; Computed tomography; Contrast media; Nephrogenic systemic fibrosis; Renal function

Indexed keywords

IOPROMIDE;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERITONEAL DIALYSIS; SOUTH KOREA; UNIVERSITY HOSPITAL;

AGED; CONTRAST MEDIA; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IOHEXOL; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHROGENIC FIBROSING DERMOPATHY; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; TIME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84868339544     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0629-z     Document Type: Article

References (12)

1. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143-9.
2. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995;47:254-61.
3. Weisbord SD, Palevsky PM. Radiocontrast-induced acute renal failure. J Intensive Care Med. 2005;20:63-75.
4. Bettmann MA. Contrast medium-induced nephropathy: critical review of the existing clinical evidence. Nephrol Dial Transplant. 2005;20(Suppl 1):i12-7.
5. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005;68:14-22.
6. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH. Role of endothelin and prostaglandins in radiocontrastinduced renal artery constriction. Kidney Int. 1993;44:1217-23.
7. Pflueger A, Larson TS, Nath KA, King BF, Gross JM, Knox FG. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc. 2000;75:1275-83.
8. Heinrich MC, Kuhlmann MK, Grgic A, Heckmann M, Kramann B, Uder M. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology. 2005;235:843-9.
9. Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243:148-57.
10. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007;242:647-9.
11. Perazella MA. Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol. 2009;4:461-9.
12. Othersen JB, Maize JC, Woolson RF, Budisavljevic MN. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure. Nephrol Dial Transplant. 2007;22:3179-85.